Suchergebnisse - "Kessler, Craig M."

PubPharm (162)

1

The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges

enthalten in: Seminars in thrombosis and hemostasis | 2024

von Tiu, A. | Chiasakul, T. | Kessler, C.

2

Association of patient, treatment and disease characteristics with patient-reported outcomes : Results of the ECHO Registry

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2024

von Hay, C. | Makris, M. | Shima, M. | +5

3

Association of patient, treatment and disease characteristics with patient‐reported outcomes : Results of the ECHO Registry

enthalten in: Haemophilia | 2024

von Hay, C. | Makris, M. | Shima, M. | +5

4

PFA-100 System : A New Method for Assessment of Platelet Dysfunction

enthalten in: Seminars in thrombosis and hemostasis | 2023

von Mammen, E. | Comp, P. | Gosselin, R. | +6

5

Clinical efficacy of simoctocog alfa versus extended half-life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching-adjusted indirect comparison method

enthalten in: European journal of haematology | 2023

von Kessler, C. | Corrales-Medina, F. | Mannucci, P. | +2

6

Emicizumab : the hemophilia A game changer

enthalten in: Haematologica | 2023

von Alcedo Andrade, P. | Mannucci, P. | Kessler, C.

7

Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment : A systematic literature review

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2023

von Mannucci, P. | Kessler, C. | Germini, F. | +5

8

Corrigendum to 'Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis' [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Pipe, S. | Trzaskoma, B. | Minhas, M. | +7

ErratumFor: Res Pract Thromb Haemost. 2023 Feb 08;7(2):100077. - PMID 36908770

9

Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Pipe, S. | Trzaskoma, B. | Minhas, M. | +7

ErratumIn: Res Pract Thromb Haemost. 2023 May 27;7(4):100191. - PMID 37538504

10

Clinical efficacy of simoctocog alfa versus extended half‐life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching‐adjusted indirect comparison method

enthalten in: European Journal of Haematology | 2023

von Kessler, C. | Corrales‐Medina, F. | Mannucci, P. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]